Recruiting
Cytomegalovirus infection+1
RecruitingRegistered drugNo placebo
A Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment
Registered drugNo placebo
- Disease:Cytomegalovirus infectionAllogenic stem cell transplantation
- Substances:Maribavir
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Maribavir
- Sponsor:Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare





